Literature DB >> 26770251

The Use of Complementary and Alternative Medicine by Korean Breast Cancer Women: Is It Associated with Severity of Symptoms?

Jung Hye Hwang1, Woon-Yong Kim2, Mansoor Ahmed3, Soojeung Choi3, Jiwoo Kim3, Dong Woon Han3.   

Abstract

Background. Use of complementary and alternative medicine (CAM) among patients with breast cancer could be associated with severity of the cancer symptoms experienced, but there is little evidence to prove this. This study tried to investigate any difference in the severity of breast cancer symptoms between CAM users and nonusers. Methods. The study followed cross-sectional design using structured survey questionnaire. Survey participants were recruited from four different healthcare settings in Seoul, South Korea. The survey instrument comprised 39 items including questions on demographics, use of CAM, and six main symptoms associated with breast cancer and cancer treatment. Results. Out of 288 participants, 67% stated using one or more modalities of CAM. Age, education, and time duration since diagnosis of cancer were significantly associated with use of CAM. About 90% of the CAM users experienced side effects of cancer treatment. CAM users reported more severe anxiety and skin/hair changes than nonusers. Conclusions. CAM was used by those breast cancer patients who experience more severe symptoms to alleviate the conditions associated with breast cancer and cancer treatment. Our findings revealed motivation behind the CAM use, which has profound implications for clinicians to recognize patient-perceived needs.

Entities:  

Year:  2015        PMID: 26770251      PMCID: PMC4681796          DOI: 10.1155/2015/182475

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


1. Introduction

Breast cancer is a chronic disease associated with severe physical and emotional burden [1]. Results of a five-year observational cohort study in the UK showed presence of depression, anxiety, or both in nearly 50% of the women with breast cancer [2], and pain, fatigue, anorexia, and skin changes are common over the course of the disease and its treatment [3]. For managing these cancer-associated symptoms, there are few approved standard guidelines; therefore, as compared to patients with other cancers, use of complementary and alternative medicine (CAM) is most common among breast cancer women [4]. Such increase in popularity of CAM might be due to the breast cancer patients' dissatisfaction with conventional therapies so they could integrate it with use of CAM [5]. Furthermore, research suggests that symptom management is one of the most common reasons behind CAM use among women with breast cancer [6, 7]. We hypothesize that use of CAM could be associated with severity of symptoms experienced by women with breast cancer. However, no conclusive research has been conducted to establish relationship between use of CAM and severity of symptoms associated with breast cancer and its treatment [8]. A number of studies have underscored high prevalence of CAM among women with breast cancer [9-12]. The variety of CAM therapies used and the factors related to CAM use have also been recognized by several researchers. A study reported that dietary supplements are the most preferred type of CAM used by women with breast cancer, while another study reported that meditation, herbs, and spiritual healing are the most commonly used modalities of CAM among such patients [13, 14]. Wanchai et al. demonstrated that women with breast cancer with higher level of education, higher income level, and younger age have increased tendency to be consumers of CAM [15]. In Korea, breast cancer is the most common type of cancer among female population and the prevalence has been increasing continuously [16]. Moreover, the most recent report reveals that more than 50% of the Korean women with breast cancer experience cancer-associated anxiety and depression [17]. Few studies have focused on the use of CAM among women with breast cancer in Korea; however, they did not investigate why these women use CAM. A survey on 160 Korean women with breast cancer highlighted the CAM usage by 36% of the participants [18]. The more recent survey conducted on the breast cancer patients in Korea reported the use of CAM by 57.4% of the patients [19]. The study discussed only quality of life indicators among CAM users and nonusers [19]. To the best of our knowledge, the surveys conducted in Asian populations so far have not studied differences in the severity of symptoms associated with breast cancer and its treatment between users of CAM and nonusers. The aim of this study is to evaluate the use of CAM in the Korean women with breast cancer by investigating differences in the severity of self-reported symptoms associated with breast cancer and its treatment between users of CAM and nonusers. Additionally, the study explored CAM users' attitudes towards CAM and conventional healthcare.

2. Methods

2.1. Participants

The study followed cross-sectional design to investigate the CAM use among South Korean female breast cancer survivors. Structured questionnaire was used to conduct face-to-face survey for three weeks from May 31, 2012, to June 20, 2012. The subjects were Korean female breast cancer patients aged over 18 years and were invited to participate in the study when they visited outpatient department of four hospitals located in Seoul, namely, Hanyang University Seoul Hospital, Hanyang University Guri Hospital, Cheil General Hospital and Women's Healthcare Centre, and Jeongpajong Breast and Thyroid Clinic. A total of 300 subjects were invited and all of them agreed to participate in the survey. Given that 12 participants did not complete the questionnaire, data of only 288 participants were included in the final analysis. Ethical approval for the study was obtained from the Institutional Review Board on Human Subjects Research and Ethics Committees, Hanyang University Guri Hospital. Prior to the survey, all participants provided IRB-approved written informed consent.

2.2. Data Collection

In order to conduct the survey in each of the facilities, four surveyors were trained. The survey questionnaire, developed in the Korean language, is comprised of a total of 39 items. Questions were asked on use of CAM, demographic characteristics, CAM users' attitudes towards conventional health care, sources of information, and severity of six self-reported symptoms, namely, pain, fatigue, depression, anorexia, skin and hair changes, and anxiety. Severity of each symptom was rated on a 6-point Likert scale from 0 to 5 (no symptom to most severe). All of the participants were asked to respond to questions on demographic characteristics, CAM use, and severity of symptoms, whereas questions related to attitudes, types of CAM, source of information, and communication were asked from CAM users only.

2.3. Statistical Analysis

Descriptive statistics (using number and percentage) were used to describe severity of symptoms, CAM users' attitudes, types of CAM, and sources of information. Linear logistic regression analysis was created (assuming confidence interval of 95%) to see any association between participants' characteristics and use of CAM. In the regression model, we considered use of CAM as dependent variable whereas independent variables comprising age, religion, education, marital status, employment, household income, family history of cancer, diagnostic institution, method of diagnosis, and time since breast cancer were diagnosed. We selected significance level of α = 0.05 for all analyses. The data were analyzed using Statistical Package for Social Sciences (SPSS) v. 18.0.

3. Results

3.1. Demographics

Table 1 displays characteristics of 288 study subjects. In terms of characteristics, 37.2% were aged >54 years, 58.7% followed Western religions (Roman Catholic, Christian), 62.5% had education up to high school, 82.6% were married, 55.2% were unemployed, 63.2% had household income <5 million KRW, 72.9% had no family history of cancer, and 54.2% were residents of Seoul.
Table 1

Participants' characteristics according to CAM use.

Characteristics CAM users Nonusers Total P value
N % N % N %
19367.09533.0288100.0
Age group0.003
 <46 5930.62728.48629.9
 46–54 7639.41920.09533.0
 >54 5830.14951.610737.2
Religion0.122
 Western 12363.74648.416958.7
 Eastern7036.34951.611941.3
Education0.027
 ≤High school11358.56770.518062.5
 ≥University 8041.52829.510837.5
Marital status0.455
 Single 3015.52021.15017.4
 Married16384.57578.923882.6
Employed0.320
 No 9951.36063.215955.2
 Yes9448.73536.812944.8
Household income0.797
 <5 million won/month11157.57174.718263.2
 ≥5 million won/month8242.52425.310636.8
Family history of cancer0.465
 No 13972.07174.721072.9
 Yes5428.02425.37827.1
Residence0.537
 Seoul 11459.14244.215654.2
 Elsewhere7940.95355.813245.8
Where diagnosed0.119
 Tertiary care hospitals 7538.94547.412041.7
 Other11861.15052.616858.3
Detected by0.616
 Screening 10956.56568.417460.4
 Symptoms8443.53031.611439.6
Months since diagnosis0.036
 <124724.43233.77927.4
 12–366533.72627.49131.6
 37–603819.71818.95619.4
 >604322.31920.06221.5

5 million Korean won (KRW) was about 4,500 US dollars at the time of survey.

3.2. Utilization of CAM and Predictors

In total, 193 (67%) participants stated utilizing one or more modalities of CAM (Table 1). Participants who were more likely to use CAM were in the age between 46 and 54 years (39.4%) and were followers of Western religions (63.7%), of higher school or lower education level (58.5%), married (84.5%), unemployed (51.3%), with household income <5 million won/month (57.5%), without family history of cancer (72%), residents of Seoul (59.1%), and with cancer diagnosed at facilities other than tertiary care hospitals (61.1%), cancer detected by screening (56.5%), and cancer diagnosed since 12–36 months (33.7%). Logistic regression analysis revealed that age, level of education, and time since diagnosis were significantly associated with use of CAM.

3.3. Severity of Symptoms

Table 2 presents Likert scale data with full frequency distributions of the scores on severity of self-reported symptoms among CAM users and nonusers. The proportion of high severity of symptoms is relatively higher among CAM users than among the nonusers, especially in the case of anxiety and skin/hair changes. Similarly, proportion of participants without symptoms is relatively higher among nonusers than among CAM users for all symptoms.
Table 2

Severity of self-reported symptoms between CAM users (193) and nonusers (95): N (%).

ScorePain FatigueDepressionAnorexiaSkin/hair changesAnxiety
CAM userNonuserCAMNonCAMNonCAMNonCAMNonCAMNon
047 (24.4)24 (25.3)19 (9.8)17 (17.9)28 (14.5)21 (22.1)22 (11.4)13 (13.7)26 (13.5)20 (21.1)21 (10.9)13 (13.7)
152 (26.9)31 (32.6)49 (25.4)35 (36.9)47 (24.4)32 (33.7)41 (21.2)28 (29.5)46 (23.8)36 (37.9)42 (21.8)31 (32.6)
217 (8.8)8 (8.4)13 (6.7)1 (1.1)11 (5.7)3 (3.2)13 (6.7)2 (2.1)15 (7.8)3 (3.2)17 (8.8)8 (8.4)
333 (17.1)12 (12.6)49 (25.4)19 (20)50 (25.9)17 (17.9)40 (20.7)20 (21.1)30 (15.5)15 (15.8)35 (18.1)21 (22.1)
419 (9.8)11 (11.6)35 (18.1)11 (11.6)30 (15.5)11 (11.6)38 (19.7)15 (15.8)33 (17.1)9 (9.5)41 (21.2)10 (10.5)
525 (13.0)9 (9.5)28 (14.5)12 (12.6)27 (14)11 (11.6)39 (20.2)17 (17.9)43 (22.3)12 (12.6)37 (19.2)12 (12.6)

3.4. Attitudes towards CAM

Table 3 shows information on CAM users' attitudes and practices regarding CAM. Out of 193 CAM users, 39.4% believed that CAM prevents progression of breast cancer and promotes health and 32.1% used it to mitigate symptoms and 19.2% used it to enhance the immune system. Moreover, 65.3% did not believe that CAM reduces costs for the treatment of breast cancer and only 32.1% believed that CAM reduces overall health care utilization. When asked who recommended them to use CAM, 40.4% responded that it was their own decision, 30.6% were advised by their family, and only 8.8% were suggested by their respective healthcare provider whereas only 48.7% believed that CAM helps in the treatment of breast cancer and 62.7% had plans to continue using any of the CAM therapies.
Table 3

CAM users' attitudes towards CAM.

Category N %
Reason for using CAM
 For cancer treatment147.3
 To prevent progress of disease 7639.4
 To mitigate symptoms6232.1
 To enhance immune system3719.2
 Other42.1
Reduces overall costs
 No12665.3
 Yes6734.7
Reduces healthcare utilization
 No13167.9
 Yes6232.1
CAM recommended by
 Myself7840.4
 Family5930.6
 Breast cancer patients2010.4
 Other relatives or friends178.8
 My healthcare provider157.7
 Other42.1
CAM helps in treatment of cancer
 No9951.3
 Yes9448.7
Plans to continue using CAM
 No7237.3
 Yes12162.7

3.5. Attitudes towards Conventional Health Care

CAM users' attitudes towards conventional health care are illustrated in Table 4. Out of 193 CAM users, 61.7% did not disclose to their healthcare providers. The reasons for not doing so were given as follows: there is no need to discuss (63.9%) and healthcare provider may dislike it (30.3%). Eighty-nine percent of the CAM users in our study had experienced one or more side effects of the conventional therapy for breast cancer.
Table 4

CAM users' attitudes towards conventional health care.

Category N %
Disclosure of CAM use to healthcare provider
 Yes7438.3
 No11961.7
Reason for nondisclosure
 Healthcare provider may dislike it3630.3
 There is no need to disclose7663.9
 I am not open-minded type00
 Healthcare provider does not know about CAM10.8
 Other65.0
Any side effects of cancer therapy
 Yes17389.6
 No2010.4

3.6. Modalities of CAM Use

Modalities of CAM used by study participants are shown in Table 5. The most common types of CAM were exercise and yoga (53.9%), ginseng (53.4%), mushrooms (46.6%), beans (43.5%), multivitamins (40.4%), and prayer, meditation, and Zen (34.2%). In aggregate, dietary and nutritional therapies were most popularly consumed, followed by mind-body interventions, alternative medicine, and biological supplements. Massage was most popularly used (20.2%) among manipulative and body-based therapies. While among alternative medicine therapies, Traditional Korean Herbal Medicine (23.3%) and acupuncture (22.3%) were most commonly used by the study participants.
Table 5

Modalities of CAM used.

CAM N %
Dietary, nutritional therapy
 Mushrooms9046.6
 Ginseng10353.4
 Beans8443.5
 Kale, Onion juice5428.0
Biological supplements
 Vitamins7840.4
 Medicinal herbs (aloe, dandelion)2211.4
 Supplements for blood circulation178.8
 Shark cartilage, Chitosan105.2
Mind-body interventions
 Prayer, Meditation, Zen6634.2
 Exercise, Yoga10453.9
 Psychotherapy147.3
 Breathing42.1
Manipulative and body-based therapies
 Massage3920.2
 Sujichim (Korean hand acupuncture)10.5
 Acupressure63.1
 Chiropractic (Chuna therapy)21.0
Alternative medicine
 Acupuncture4322.3
 Traditional Korean Herbal Medicine4523.3
 Moxibustion and Cupping147.3
 Physiotherapy00
 Other31.6

4. Discussion

This study reports the recent trend of CAM use among breast cancer survivors in South Korea. Results of our study show high prevalence of CAM utilization by 67% of the participants, which is consistent with previous studies [15, 20, 21]. However, this rate is slightly lower when compared to use of CAM among general population in Korea [22]. Consistent with previous studies, likely predictors of CAM use included age, level of education, and time since diagnosis of breast cancer [10, 15, 23]. Patterns of CAM modalities used among the study participants reflect their sociocultural background as ginseng was the most popular among nutritional therapies (53.4%), whereas the previous Korean study reported its consumption as 33.6% [19]. Overall, dietary and nutritional therapies were the most commonly consumed category of CAM, consistent with the study conducted by Fasching et al. [24]. We also found that 38.3% of the CAM users, at some point, discussed CAM use with their healthcare provider. Previous Korean studies reported this number at 20% and 29.6%, respectively [18, 19]. These numbers suggest increase in disclosure of CAM use to healthcare providers in the country. Our results show that 90% of the CAM users experienced side effects of conventional therapy for cancer, which is supported by previous studies [25, 26]. The breast cancer patients used CAM to complement conventional medical treatment, which is further confirmed by our results where majority of the CAM users believed that using CAM reduces neither overall costs of care nor healthcare utilization. Thus, as our results illustrate, participants used CAM mainly to prevent progress of disease and promote health, which is similar to findings from previous studies conducted in Korea and Malaysia [19, 27]. Another major reason for using CAM was to alleviate symptoms and to enhance immune systems, which is similar to previous research [10, 28]. In order to see any difference between CAM users and nonusers, we compared the two groups with relation to severity of self-reported symptoms. Based on the literature review and our clinical experience [2, 3, 17], we selected six symptoms for investigation: pain, fatigue, depression, anorexia, anxiety, and skin and hair changes. These symptoms can seriously affect breast cancer patients' quality of life, which they experience over the course of disease and its treatment [29, 30]. Our study found significant difference in the severity of fatigue, depression, anxiety, and skin and hair changes between CAM users and nonusers. Our results imply that CAM is used by those breast cancer patients who experience more severe symptoms. Moreover, these findings are in agreement with other results of this study where symptom management is one of the major reasons for CAM use. Previous studies also show that breast cancer patients use CAM to alleviate their symptoms [28, 31]. A study conducted in the UK found that breast cancer patients undergoing radiotherapy believed that CAM would mitigate their fatigue and skin changes [32]. About 54% of CAM users in our study were using yoga as complementary therapy. There is strong evidence of yoga therapy improving fatigue in breast cancer survivors [33]. Moreover, yoga therapy can also mitigate anxiety and other symptoms among breast cancer outpatients undergoing conventional radiotherapy and chemotherapy [34] whereas a study conducted in the United States established relationship between restorative yoga and self-reported emotional symptoms and fatigue among breast cancer patients [35]. More than 53% of the CAM users in our sample used ginseng, which is commonly used for symptoms associated with breast cancer in Asian countries [36]. Our study has produced important findings regarding the motivation behind use of CAM among breast cancer patients. Patients, who experienced more severe symptoms, might have wanted to alleviate them via using CAM, whereas patients with milder symptoms did not use CAM. Results of the study have significant implications for clinical oncology as there is evidence of side effects from CAM use [37]. Furthermore, results of the study may enable oncologists to identify breast cancer patients' needs and expectations which are otherwise difficult in the absence of strong evidence supporting the effectiveness of CAM use in such patients [38]. We recommend that oncologists should be aware of the extent to which breast cancer patients use CAM and reasons for its usage. Moreover, oncologists should initiate the communication with their patients especially those who experience more severe symptoms as our results show that a large number of patients do not disclose their use of CAM. Findings of our study have given more insight into the trend of using CAM among breast cancer patients. Further studies are suggested using larger samples in different settings to more investigate the relationship between CAM use and symptoms associated with breast cancer and its treatment.

5. Conclusions

CAM is used by breast cancer patients who experience more severe symptoms associated with breast cancer and its treatment to alleviate the symptoms. Patients' perceptions and understanding of their illness, and health benefits from CAM use, are an evolving process that may have an influence on quality of life and health behavior choices. It remains to be discovered whether this motivation behind the use of CAM is in line with true medical benefit. As new information about CAM becomes available, it will be important to develop and provide education programs for health professionals and to increase awareness among patients.
  37 in total

1.  Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?

Authors:  J S McLay; D Stewart; J George; C Rore; S D Heys
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

2.  A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer.

Authors:  Meena S Moran; Shuangge Ma; Reshma Jagsi; Tzu-I Jonathan Yang; Susan A Higgins; Joanne B Weidhaas; Lynn D Wilson; Shane Lloyd; Richard Peschel; Bryant Gaudreau; Sara Rockwell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-01       Impact factor: 7.038

3.  Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study.

Authors:  Eunyoung Kang; Eun Joo Yang; Sun-Mi Kim; Il Yong Chung; Sang Ah Han; Do-Hoon Ku; Soek-Jin Nam; Jung-Hyun Yang; Sung-Won Kim
Journal:  Support Care Cancer       Date:  2011-01-28       Impact factor: 3.603

4.  Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions.

Authors:  H Boon; M Stewart; M A Kennard; R Gray; C Sawka; J B Brown; C McWilliam; A Gavin; R A Baron; D Aaron; T Haines-Kamka
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

Review 5.  Safety issues in using complementary and alternative medicine.

Authors:  Maurie Markman
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

Review 6.  Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea.

Authors:  Sydney M Dy; Karl A Lorenz; Arash Naeim; Homayoon Sanati; Anne Walling; Steven M Asch
Journal:  J Clin Oncol       Date:  2008-08-10       Impact factor: 44.544

7.  Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer.

Authors:  Christina Gundgaard Pedersen; Søren Christensen; Anders Bonde Jensen; Robert Zachariae
Journal:  Eur J Cancer       Date:  2009-10-05       Impact factor: 9.162

8.  Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: a randomized controlled trial.

Authors:  M Raghavendra Rao; Nagarathna Raghuram; H R Nagendra; K S Gopinath; B S Srinath; Ravi B Diwakar; Shekar Patil; S Ramesh Bilimagga; Nalini Rao; S Varambally
Journal:  Complement Ther Med       Date:  2008-10-14       Impact factor: 2.446

9.  Prescription pattern of chinese herbal products for breast cancer in taiwan: a population-based study.

Authors:  Jung-Nien Lai; Chien-Tung Wu; Jung-Der Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-28       Impact factor: 2.629

10.  Use of Self-Care and Practitioner-Based Forms of Complementary and Alternative Medicine before and after a Diagnosis of Breast Cancer.

Authors:  Alissa R Link; Marilie D Gammon; Judith S Jacobson; Page Abrahamson; Patrick T Bradshaw; Mary Beth Terry; Susan Teitelbaum; Alfred Neugut; Heather Greenlee
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-12       Impact factor: 2.629

View more
  16 in total

Review 1.  Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.

Authors:  John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.650

2.  Complementary and alternative medicine use among patients with cancer in Mongolia: a National hospital survey.

Authors:  Buyadaa Oyunchimeg; Jung Hye Hwang; Mansoor Ahmed; Soojeung Choi; Dongwoon Han
Journal:  BMC Complement Altern Med       Date:  2017-01-19       Impact factor: 3.659

3.  Dietary supplement use among cancer survivors and the general population: a nation-wide cross-sectional study.

Authors:  Sihan Song; Jiyoung Youn; Yun Jung Lee; Minji Kang; Taisun Hyun; YoonJu Song; Jung Eun Lee
Journal:  BMC Cancer       Date:  2017-12-28       Impact factor: 4.430

4.  Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia.

Authors:  Noor Mastura Mohd Mujar; Maznah Dahlui; Nor Aina Emran; Imisairi Abdul Hadi; Yan Yang Wai; Sarojah Arulanantham; Chea Chan Hooi; Nur Aishah Mohd Taib
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

5.  Complementary and Alternative Medicine Use and Its Association with Emotional Status and Quality of Life in Patients with a Solid Tumor: A Cross-Sectional Study.

Authors:  Aelee Jang; Duck-Hee Kang; Dong Uk Kim
Journal:  J Altern Complement Med       Date:  2017-04-28       Impact factor: 2.579

6.  Complementary and alternative medicine use among outpatients during the 2015 MERS outbreak in South Korea: a cross-sectional study.

Authors:  Jung Hye Hwang; Hyun Jeong Cho; Hyea Bin Im; Young Sun Jung; Soo Jeung Choi; Dongwoon Han
Journal:  BMC Complement Med Ther       Date:  2020-05-13

7.  Mindfulness-Based Stress Reduction on breast cancer symptoms: systematic review and meta-analysis.

Authors:  Flavia Del Castanhel; Rafaela Liberali
Journal:  Einstein (Sao Paulo)       Date:  2018-12-06

Review 8.  Complementary and Alternative Medicines and Patients With Breast Cancer: A Case of Mortality and Systematic Review of Patterns of Use in Patients With Breast Cancer.

Authors:  Grayson A Roumeliotis; Genevieve Dostaler; Kirsty U Boyd
Journal:  Plast Surg (Oakv)       Date:  2017-08-22       Impact factor: 0.947

9.  Quality of life and complementary and alternative medicine use among women with breast cancer.

Authors:  Hadeel Albabtain; Monira Alwhaibi; Khalid Alburaikan; Yousif Asiri
Journal:  Saudi Pharm J       Date:  2018-01-03       Impact factor: 4.330

10.  Cancer- and Chemotherapy-Related Symptoms and the Use of Complementary and Alternative Medicine.

Authors:  Ping Lei Chui
Journal:  Asia Pac J Oncol Nurs       Date:  2019 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.